These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31588731)

  • 1. Ultra-Sensitive Detection and Inhibition of the Metastasis of Breast Cancer Cells to Adjacent Lymph Nodes and Distant Organs by Using Long-Persistent Luminescence Nanoparticles.
    Liu H; Ren F; Zhou X; Ma C; Wang T; Zhang H; Sun Q; Li Z
    Anal Chem; 2019 Dec; 91(23):15064-15072. PubMed ID: 31588731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Imaging for Detecting Metastasis to Level II and III Axillary Lymph Nodes after Axillary Lymph Node Dissection for Invasive Breast Cancer.
    Lin X; An X; Xiang H; Pei X; Li A; Tang G
    J Ultrasound Med; 2019 Nov; 38(11):2925-2934. PubMed ID: 30912182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
    Sun SK; Wang HF; Yan XP
    Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro diagnosis of axillary lymph node metastases in breast cancer by spectrum analysis of radio frequency echo signals.
    Tateishi T; Machi J; Feleppa EJ; Oishi R; Jucha J; Yanagihara E; McCarthy LJ; Noritomi T; Shirouzu K
    Ultrasound Med Biol; 1998 Oct; 24(8):1151-9. PubMed ID: 9833584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of metastatic niches in distant organs after surgical removal of tumor-bearing lymph nodes.
    Zheng J; Jia L; Mori S; Kodama T
    BMC Cancer; 2018 May; 18(1):608. PubMed ID: 29848296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.
    Turner RR; Ollila DW; Krasne DL; Giuliano AE
    Ann Surg; 1997 Sep; 226(3):271-6; discussion 276-8. PubMed ID: 9339933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems concerning patients' qualification for surgical procedures allowing for evaluation of the condition of axillary fossa lymph nodes in the radical treatment of breast cancer.
    Nowikiewicz T; Śrutek E; Zegarski W
    Pol Przegl Chir; 2015 Jun; 87(6):290-4. PubMed ID: 26247499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast.
    Kurosumi M; Suemasu K; Tabei T; Inoue K; Matsumoto H; Sugamata N; Higashi Y
    Oncol Rep; 2001; 8(5):1051-5. PubMed ID: 11496315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models.
    Pu T; Liu Y; Pei Y; Peng J; Wang Z; Du M; Liu Q; Zhong F; Zhang M; Li F; Xu C; Zhang X
    ACS Appl Mater Interfaces; 2023 Jul; 15(27):32226-32239. PubMed ID: 37385963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
    Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
    Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
    Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
    Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma].
    Berclaz G; Crazzolara AO; Altermatt HJ; Aebi S; Fey MF; Hänggi W; Dreher E
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1730-6. PubMed ID: 9846346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
    Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
    Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
    Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.